loadpatents
Patent applications and USPTO patent grants for LABROLI; Marc A..The latest application filed is for "oxazolidinones as taro inhibitors".
Patent | Date |
---|---|
Benzimidazoles And Indoles As Taro Inhibitors App 20210346344 - CALDWELL; John P. ;   et al. | 2021-11-11 |
Oxazolidinones As Taro Inhibitors App 20210346364 - CALDWELL; John P. ;   et al. | 2021-11-11 |
Benzimidazoles and indoles as taro inhibitors Grant 11,141,403 - Caldwell , et al. October 12, 2 | 2021-10-12 |
Oxazolidinones as taro inhibitors Grant 11,141,410 - Caldwell , et al. October 12, 2 | 2021-10-12 |
Oxazolidinones As Taro Inhibitors App 20200261436 - CALDWELL; John P. ;   et al. | 2020-08-20 |
Benzimidazoles And Indoles As Taro Inhibitors App 20200261410 - CALDWELL; John P. ;   et al. | 2020-08-20 |
Anilinopiperazine derivatives and methods of use thereof Grant 9,206,142 - Shipps, Jr. , et al. December 8, 2 | 2015-12-08 |
Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors Grant 8,603,998 - Guzi , et al. December 10, 2 | 2013-12-10 |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors Grant 8,580,782 - Guzi , et al. November 12, 2 | 2013-11-12 |
Thiazole Derivatives as protein kinase inhibitors Grant 8,476,278 - Reddy , et al. July 2, 2 | 2013-07-02 |
Anilinopiperazine Derivatives And Methods Of Use Thereof App 20120328691 - Shipps, JR.; Gerald W. ;   et al. | 2012-12-27 |
Piperazine derivatives useful as CCR5 antagonists Grant 8,114,879 - Baroudy , et al. February 14, 2 | 2012-02-14 |
Synthesis Of Substituted-3-aminopyrazoles App 20120029204 - Alvarez; Carmen S. ;   et al. | 2012-02-02 |
Novel Modulators Of Cell Cycle Checkpoints And Their Use In Combination With Checkpoint Kinase Inhibitors App 20110183933 - Guzi; Timothy J. ;   et al. | 2011-07-28 |
Thiazole Derivatives as Protein Kinase Inhibitors App 20100331313 - Reddy; Panduranga Adulla P. ;   et al. | 2010-12-30 |
Piperidine Derivatives Useful As Ccr5 Antagonists App 20080188485 - Baroudy; Bahige M. ;   et al. | 2008-08-07 |
Piperazine derivatives useful as CCR5 antagonists Grant 7,384,944 - Baroudy , et al. June 10, 2 | 2008-06-10 |
Piperazine derivatives useful as CCR5 antagonists App 20040067961 - Baroudy, Bahige M. ;   et al. | 2004-04-08 |
Piperazine derivatives useful as CCR5 antagonists Grant 6,689,765 - Baroudy , et al. February 10, 2 | 2004-02-10 |
Piperazine derivatives useful as CCR5 antagonists App 20030069252 - Baroudy, Bahige M. ;   et al. | 2003-04-10 |
Piperazine derivatives useful as CCR5 antagonists Grant 6,391,865 - Baroudy , et al. May 21, 2 | 2002-05-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.